- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Advanced Thyroid Cancer Controversy and Consensus ; volume:41 ; number:04 ; year:2020 ; pages:476-480
Indian journal of medical & paediatric oncology ; 41, Heft 04 (2020), 476-480
- Contributor
-
Rao, Karthik
Deshmukh, Anuja
Pai, Prathamesh
Pantvaidya, Gouri
- DOI
-
10.4103/ijmpo.ijmpo_145_20
- URN
-
urn:nbn:de:101:1-2021082715121900428021
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rao, Karthik
- Deshmukh, Anuja
- Pai, Prathamesh
- Pantvaidya, Gouri
Other Objects (12)
The case-control study consensus and controversy
Controversy and consensus: nuclear beta decay 1911 - 1934
Energy Transition in Japan: From Consensus to Controversy
Energy Transition in Japan: From Consensus to Controversy
Treatment of advanced thyroid cancer refractory to therapy
Renal replacement therapy in acute kidney injury: controversy and consensus
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Controversy
Controversy
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Advanced Breast Cancer : AGO Recommendations 2022 – Focus on ABC6 Consensus
Thyroid cancer
The case-control study consensus and controversy
Controversy and consensus: nuclear beta decay 1911 - 1934
Energy Transition in Japan: From Consensus to Controversy
Energy Transition in Japan: From Consensus to Controversy
Treatment of advanced thyroid cancer refractory to therapy
Renal replacement therapy in acute kidney injury: controversy and consensus
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Controversy
Controversy
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Advanced Breast Cancer : AGO Recommendations 2022 – Focus on ABC6 Consensus
Thyroid cancer
The case-control study consensus and controversy
Controversy and consensus: nuclear beta decay 1911 - 1934
Energy Transition in Japan: From Consensus to Controversy
Energy Transition in Japan: From Consensus to Controversy
Treatment of advanced thyroid cancer refractory to therapy
Renal replacement therapy in acute kidney injury: controversy and consensus
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Controversy
Controversy
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
Advanced Breast Cancer : AGO Recommendations 2022 – Focus on ABC6 Consensus